• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join PRI
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence

Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence

by Camille Bello | Jun 19, 2025 | News & Events

In 2024, the European Commission launched a legislative initiative to establish the “EU Biotech Act,” with the ambitious goal of accelerating the transition of biotechnology products from research to market, while maintaining high safety standards for people and the...

The regulatory framework for microbiome-based therapies: insights into European regulatory developments

by Camille Bello | May 16, 2025 | PRI Publications

Julie Rodriguez, Magali Cordaillat-Simmons, Bruno Pot, Céline Druart. NPJ Biofilms Microbiomes. 2025 Mar 28;11(1):53. doi: 10.1038/s41522-025-00683-0.  Abstract: The emergence of a broad spectrum of microbiome-based therapies has triggered changes in European...
Next Entries »

Recent News & Events

  • Status of Isolated Microbial Strains: Joint Position of PRI and IPA Europe with Technical Clarifications and Legal References
  • Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence
  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Association internationale sans but lucratif (droit beige) – 34/ 36 rue Breydel, 1040- Bruxelles, Belgium.

Agence de communication : Frelonbleu